Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
The AIDS Reader|July 1, 2008
Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patientsLynda C Doward, Birgitta Dietz, Jeanette Wilburn, et al.Clinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopeniaGabriel Tremblay, Mike Dolph, Menaka Bhor, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2021
For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reportsJason Shafrin, Syvart Dennen, Priti Pednekar, et al.Journal of Health Economics and Outcomes Research|March 6, 2023
Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based StudyHyeun Ah Kang, Jamie C Barner, Kristin M Richards, et al.Journal of Health Economics and Outcomes Research|July 21, 2020
Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based StudyHyeun Ah Kang, Jamie C Barner, Kristin M Richards, et al.Health and Quality of Life Outcomes|May 23, 2018
Systematic literature review and assessment of patient-reported outcome instruments in sickle cell diseaseGrammati Sarri, Menaka Bhor, Seye Abogunrin, et al.Journal of Comparative Effectiveness Research|June 1, 2018
A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonistsMike Dolph, Anuja Roy, Menaka Bhor, et al.Clinical Genitourinary Cancer|March 7, 2015
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology PracticesGuru Sonpavde, Menaka Bhor, Daniel Hennessy, et al.Cost Effectiveness and Resource Allocation : C/E|May 10, 2011
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial dataKit N Simpson, Birgitta Dietz, Robert W Baran, et al.Journal of Health Economics and Outcomes Research|March 8, 2023
Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett's Esophagus, and Barrett's Esophagus-Related Neoplasia in the United StatesPrateek Sharma, Gary W Falk, Menaka Bhor, et al.Pageof 3